3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
16
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Stomach Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Diabetes Mellitus, Insulin-Dependent, 12
2
Carcinoma, Non-Small-Cell Lung
2
Resectable MMR-deficient Solid Tumors
1
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Cancer Metastatic
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Microsatellite Stable Rectal Carcinoma
1
Melanoma
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Cancer Metastatic
1
Carcinoma, Renal Cell
1
Interventions
Injections
13
pembrolizumab
10
tislelizumab
9
toripalimab
6
atezolizumab
4
Nivolumab
4
Carboplatin
3
trastuzumab deruxtecan
2
olaparib
2
lenvatinib
2
Pemetrexed
2
Paclitaxel
2
Oxaliplatin
2
Gemcitabine
2
Fluorouracil
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Bevacizumab
2
zimberelimab
1
talazoparib
1
spartalizumab
1
sotorasib
1
serabelisib
1
penpulimab
1
niraparib
1
nedaplatin
1
mirdametinib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
balstilimab
×
1 year
×
Clear all
No trials found.